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ABSTRACT
In metazoans, replication-dependent histone
mRNAs end in a stem-loop structure instead of the
poly(A) tail characteristic of all other mature mRNAs.
This specialized 30 end is bound by stem-loop
binding protein (SLBP), a protein that participates
in the nuclear export and translation of histone
mRNAs. The translational activity of SLBP is
mediated by interaction with SLIP1, a middle
domain of initiation factor 4G (MIF4G)-like protein
that connects to translation initiation. We
determined the 2.5 Å resolution crystal structure of
zebrafish SLIP1 bound to the translation–activation
domain of SLBP and identified the determinants of
the recognition. We discovered a SLIP1-binding
motif (SBM) in two additional proteins: the transla-
tion initiation factor eIF3g and the mRNA-export
factor DBP5. We confirmed the binding of SLIP1 to
DBP5 and eIF3g by pull-down assays and
determined the 3.25 Å resolution structure of SLIP1
bound to the DBP5 SBM. The SBM-binding and
homodimerization residues of SLIP1 are conserved
in the MIF4G domain of CBP80/20-dependent trans-
lation initiation factor (CTIF). The results suggest
how the SLIP1 homodimer or a SLIP1–CTIF
heterodimer can function as platforms to bridge
SLBP with SBM-containing proteins involved in dif-
ferent steps of mRNA metabolism.
INTRODUCTION
The vast majority of eukaryotic mRNAs contain a string
of adenosines at the 30 end of the transcript, the so-called
poly(A) tail. The poly(A) tail is added in the nucleus after
transcription and is the binding site for the poly(A)-
binding protein (PABP) [reviewed in (1)]. PABP is an
integral part of the mature messenger ribonucleoprotein
particle (mRNP) that is exported to the cytoplasm. In the
cytoplasm, PABP interacts with the eukaryotic initiation
factor 4G (eIF4G), which in turn is recruited to the 50 end
of the transcript (2,3). The network of interactions con-
necting the 30 and 50 ends of an mRNA promotes transla-
tion initiation and hampers degradation [reviewed in (4)].
Mammalian mRNAs transcribed from replication-de-
pendent histone genes are the exception to the norm.
Histones are massively produced during S-phase to
assemble the newly synthesized genomic DNA into chro-
matin and their expression bypasses many of the conven-
tional mechanisms used by other cellular mRNAs
[reviewed in (5,6)]. One of the idiosyncratic features of
these histone mRNAs is that they lack a poly(A) tail.
Instead, they end with a stem-loop structure in the 30
UTR that is the binding site for the stem-loop binding
protein (SLBP, also known as hairpin-binding protein or
HBP) (7,8). SLBP plays pivotal roles in the metabolism of
histone mRNA, much in the same way as PABP for other
cellular mRNAs [reviewed in (5,6)].
SLBP is synthesized just before the entry into S-phase
(9) and is imported into the nucleus by the importin
a-importin b transport factors (10). SLBP is believed to
bind the stem-loop co-transcriptionally and to stabilize the
interactions leading to 30 end processing (11). The mature
histone mRNP with bound SLBP is rapidly exported to
the cytoplasm via the canonical mRNA transport factor
TAP (10,12,13). In mammalian cells, SLBP appears to
have an active role in the export process, as depletion of
SLBP by RNA interference results in a substantial nuclear
accumulation of fully processed histone mRNAs and
consequently leads to cell-cycle arrest (14–16). In the cyto-
plasm, SLBP is required for efficient translation of histone
mRNAs and protects them from degradation (17,18).
SLBP is eventually phosphorylated and degraded by the
proteasome at the end of the S-phase (19).
SLBP has a modular domain organization characterized
by large regions of intrinsic disorder. The central region of
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SLBP folds on binding the histone RNA stem-loop, re-
sulting in a tight interaction with nanomolar affinity
(20,21). The central and the C-terminal regions of SLBP
are involved in 30 end processing (22). The N-terminal
region contains a short segment of 15 residues that is
essential for the activation of histone mRNA translation
(18). The translation–activation segment of SLBP is
located near the phosphorylation sites and is the binding
site for a middle domain of initiation factor 4G (MIF4G)-
like protein known as SLBP-binding protein 1 (SLIP1) or
MIF4GD (23). SLIP1 cooperates with SLBP to activate
histone mRNA translation (23) and interacts, either
directly or indirectly, with the eIF3 translation initiation
complex (17,24). In contrast to SLBP, SLIP1 is an essen-
tial protein in cultured mammalian cells (23). How the
small compact fold of SLIP1 might harbor multiple func-
tional sites to recruit different proteins and enhance trans-
lation is unclear. Also unknown is whether SLIP1 might
have additional functions. In this work, we elucidated the
determinants of the SLIP1–SLBP interaction and shed
light on how SLIP1 can directly and concomitantly
recruit SLBP together with proteins involved in transla-
tion initiation and nuclear export.
MATERIALS AND METHODS
Protein purification
Human and zebrafish full-length (f.l.) SLIP1 were
subcloned as TEV-cleavable GST-tagged proteins and ex-
pressed at 18C in Escherichia coli BL21(DE3) cells using
auto-inducing medium (25). They were purified by affinity
chromatography (GSH-Sepharose 4B, GE Healthcare)
followed by cleavage of the GST tag by TEV protease
and size-exclusion chromatography (Superdex 200, GE
Healthcare). For pull-down assays, the GST tag was left
uncleaved. A similar protocol was used to express and
purify zebrafish SLBP residues 89–105 (SLBP89–105),
zebrafish DBP51–32 and human DBP5 f.l. (residues
1–479), DBP5N (residues 68–479), DBP5NC
(residues 68–302) and DBP51–51. Mutations were
introduced into f.l. human DBP5 by the Quik-Change
site-directed mutagenesis system (Stratagene) and ex-
pressed and purified as described above. Human and
zebrafish SLIP1–SLBP and SLIP1–DBP5 complexes
were reconstituted by mixing equimolar amounts of the
purified proteins for 2 h at 4C and further purified by
size exclusion chromatography (in 20mM Hepes, pH
7.5, 100mM NaCl and 1mM DTT). All samples were
tested for monodispersity by coupling a Superdex 200
column to a static light scattering device (TDA302,
Viscotech).
Crystallization and structure determination
The complex of Danio rerio (D.r.) SLIP1 and SLBP89–105
was concentrated to 16mg ml1 and subjected to crystal-
lization experiments at 18C using sitting-drop vapor dif-
fusion. Crystals were obtained using a reservoir solution
consisting of 0.17M K/Na-tartrate, 0.085M Na-citrate,
pH 5.6, 1.7M ammonium sulfate and 15% glycerol. The
complex of D.r. SLIP1 and DBP51–32 crystallized at 18
C
at a concentration of 20mg ml1 using a reservoir solution
consisting of 0.05M MES, pH 6.0, 18% (w/v) PEG 8000,
0.2M Ca-Acetate. The crystals were cryoprotected with
the addition of 15% (w/v) PEG 400 to the reservoir
solution before data collection. Diffraction data were col-
lected at 100K at the Swiss Light Source synchrotron
(SLS Villigen, Switzerland) and were processed with
XDS (26). The crystals of D.r. SLIP1–SLBP89–105 belong
to spacegroup P6522, contain one molecule per asymmet-
ric unit and diffracted to 2.5 Å resolution (statistics in
Table 1). The crystals of D.r. SLIP1–DBP51–32 belong to
spacegroup P6122, contain two molecules per asymmetric
unit and diffracted to 3.25 Å resolution (statistics in
Table 1). Both structures were solved by molecular re-
placement with the program Phaser (27) using D.r.
SLIP1 (PDB entry 2I2O) as a search model. The models
were manually built using Coot (28) and refined using
Refmac5 (29) and Phenix (30). The SLIP1–SLBP89–105
structure was refined to Rfree of 24.3%, Rwork of 19.2%
and good stereochemistry (statistics in Table 1). In the
case of the SLIP1–DBP51–32 structure, the two independ-
ent molecules in the asymmetric unit were refined using
tight non-crystallographic symmetry restraints, which
were released in the final stages of refinement. The final
model of DBP51–32 has an Rfree of 27.2%, Rwork of 24.5%
and more 98% of the residues in the most favored regions
of the Ramachandran plot (statistics in Table 1).
In vitro binding assays
RNA-binding experiments were performed as previously
described (31) using 50 end-biotinylated U20 ssRNA
(Dharmacon). Briefly, 2 mg of DBP5 proteins was
incubated in binding buffer in the presence or absence of
1mM AMPPNP and 170 nM U20 RNA. Samples were
incubated overnight at 4C. Magnetic streptavidin beads
(50mg; Dynal) were added for 1 h. Beads were washed
three times with 0.5ml binding buffer. Samples were
eluted in sodium dodecyl sulphate (SDS) loading buffer
and were analyzed by SDS polyacrylamide gel electro-
phoresis (PAGE).
GST-pull-down experiments with purified proteins were
carried out as described (31). About 2mg of GST-tagged
recombinant DBP5 proteins were immobilized on 20 ml of
glutathione sepharose beads (GE Healthcare) per binding
reaction. After a 2-h incubation, beads were washed three
times with 1ml binding buffer (20mM Hepes, pH7.5,
100mM NaCl, 1mM DTT, 10mM MgCl2 supplemented
with 0.1% (v/v) Nonidet P40). A 2-fold excess of SLIP1
proteins was added to a final volume of 100 ml binding
buffer per reaction. After a 2-h incubation, beads were
washed three times with 1ml binding buffer. Bound
proteins were eluted with SDS sample buffer and
analyzed with SDS PAGE.
GST pull-down experiments with in vitro translated
proteins were carried out as previously described (23) by
labeling proteins with 35S-methionine in rabbit reticulo-
cyte lysate and carrying out the pull-down reaction with
different GST-SLIP1 fusion proteins.
Isothermal titration calorimetry (ITC) experiments were
performed on a VP-ITC microcalorimeter from Microcal
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at 25C equipped with a 300ml syringe (Microcal, GE
healthcare). SLIP1 and the different DBP5 constructs
tested were dialyzed in the same gel filtration buffer over-
night. We titrated 10 mM of SLIP1 in a cell volume of
1.44ml with 100 mM of different DBP5 constructs in 28
injections of 10 ml volumes at 5 min intervals. The released
heat was obtained by integrating the calorimetric output
curves. The Kd values and binding ratios were calculated
with the Origin5 software supplied with the instrument.
In vivo protein interactions
HeLa cells were stably transformed with an N-terminally
tagged HA-DBP5 cloned in pcDNA3 and stable cells ex-
pressing the tagged DBP5 in similar amounts to the en-
dogenous protein were selected. Immunoprecipitations
were carried out as previously described (23), after pre-
cipitation with either anti-HA antibody to precipitate
the tagged DBP5 or with anti-SLIP1 antibody to
precipitated endogenous SLIP1. We were able to detect
both the tagged DBP5 (with the anti-HA antibody)
and the endogenous DBP5 when the immunoprecipitation
was carried out with the anti-SLIP1 from untransfected
cells.
RESULTS AND DISCUSSION
Structure determination of SLIP1 bound to the
N-terminus of SLBP
Previous studies identified residues 68–83 of Xenopus
SLBP1 as the translation activation segment that is essen-
tial for binding to SLIP1 (18,23). This region is
intrinsically disordered with a propensity to form a tran-
sient helical structure (21,32). To obtain diffracting
crystals of a SLIP1–SLBP complex, we took advantage
of the evolutionary conservation of these proteins.
SLIP1 is overall highly conserved, with the Xenopus,
human and zebrafish orthologues sharing >70%
sequence identity. The SLIP1-binding region of SLBP is
also highly conserved in vertebrates.
The complex between zebrafish SLIP1 and a fragment
of zebrafish SLBP encompassing residues 89–105
(SLBP89–105, corresponding to Xenopus 68–84) yielded
crystals that diffracted to 2.5 Å resolution and contain
one complex in the asymmetric unit. We determined the
structure by molecular replacement using the SLIP1 co-
ordinates deposited in the PDB (code 2I2O) from the
Center for Eukaryotic Structural Genomics Consortium
(Madison, Wisconsin). The final atomic model of the
SLIP1–SLBP complex is refined to Rfree of 24.3%, Rwork
of 19.2% and good stereochemistry (Table 1). The struc-
ture consists of residues 7–218 of SLIP1 and residues 89–
105 of SLBP (with an additional N-terminal GPLGSM
sequence from the expression vector that mediates
crystal contacts with a neighboring SLIP1 molecule in
the lattice). Comparison with the apo structure of SLIP1
indicates that binding of SLBP does not cause major con-
formational changes. More than 90% of the amino-acid
residues superpose over all atom positions with a root
mean square deviation (r.m.s.d.) of <0.6 Å.
SLIP1 is a non-canonical MIF4G-like protein
SLIP1 is an all a-helical protein (Figure 1A). The sec-
ondary structure includes 10 a-helices (a1–a10) consisting
of 11–22 residues each and arranged in an antiparallel
fashion. Eight helices (a2–a9) have the characteristic ar-
rangement found in HEAT-repeat proteins. HEAT
repeats are 40 amino acids motifs that fold into
helical hairpins formed by two antiparallel a-helices,
known as A and B helices (33). In HEAT-repeat
proteins, multiple helical hairpins pack against each
other consecutively and in a parallel fashion, giving rise
to solenoid structures [reviewed in (34)]. The regular
topology of secondary structure elements results in the
A and B helices lining the outer convex surface and the
inner concave surface of the solenoid, respectively.
Database searches for structural similarities to SLIP1
using the program Dali (35) identified the HEAT-
repeat fold of MIF4G. In contrast to MIF4G-like
domains, however, SLIP1 contains only four of the ca-
nonical five HEAT repeats (HEAT 2–5, between a2–a9)
(Figure 1B). Instead of a parallel helical hairpin as
HEAT 1, SLIP1 features a single helix that packs per-
pendicular to the helices of HEAT 2. Another unusual
feature of SLIP1 is the C-terminal helix (a10). Helix a10
deviates from the HEAT-repeat architecture and forms a
C-terminal extension that interacts intra-molecularly with
the concave surface of the solenoid, against the side of
HEAT 5 (a9, Figure 1). In addition, helix a10 interacts
inter-molecularly with helix a8 in the second monomer of
SLIP1 present in the crystal lattice.
Table 1. Data collection and refinement statistics
SLIP1–SLBP SLIP1–DBP5
Data collection
Space group P6522 P6122
Cell dimensions
a, b, c (Å) 70.65, 70.65, 242.55 85.22, 85.22, 258.4
a, b, g () 90, 90, 120 90, 90, 120
Resolution (Å) 43.07-2.50 (2.60-2.50) 86.13-3.25 (3.45-3.25)
Rmeas 11.4 (75.9) 8.3 (68.2)
I/I 13.18 (2.01) 16.34 (2.30)
Completeness (%) 99.9 (99.9) 99.8 (100)
Redundancy 6.14 (6.1) 4.5 (4.6)
Refinement
Resolution (Å) 43.07 - 2.50 73.77 - 3.25









Bond lengths (Å) 0.008 0.0066
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A conserved convex surface of SLIP1 interacts
with SLBP
Zebrafish SLBP89–105 folds into an a-helix encompassing
residues 94–105 and flanked by an N-terminal segment.
The helix docks at the convex surface of SLIP1, binding
between the outer helices of HEAT 3 and 4 (a4 and a6,
Figures 1 and 2A). The interaction is centered at the highly
conserved Trp94 and Val98 of D.r. SLBP (Figure 2C),
which are recognized at a shallow hydrophobic pocket on
SLIP1 lined by Leu80, Leu83, Phe87, Ala124, Leu125 and
Pro128 (Figure 2A). The conserved acidic residues Asp96,
Glu99 and Glu102 in SLBP interact with SLIP1 Arg77 and
Arg76. Polar contacts engage SLBP Asn93 with SLIP1
Asn81 and Gln84. SLIP1 Asn81 also contacts the SLBP
main chain at Gly95. These interactions are highly
conserved in metazoans (Figure 2B and C). Consistently,
a single point mutation of Xenopus SLBP at Trp75 (corres-
ponding to Trp94 in the D.r. orthologue) has been shown
to abolish the interaction with SLIP1 and the translation
stimulation activity of SLBP (23). Conversely, mutation of
exposed polar residues lining in the Trp-binding pocket of
human SLIP1 (Arg77, Asn81 and Gln84 to alanine
residues) resulted in loss of SLBP binding in pull-down
assays (Figure 2D).
It has recently been shown that SLBP interacts with the
protein CTIF (CBP80/20-dependent translation initiation
factor) and that the interaction is impaired when human
SLBP Trp75 is mutated (36). CTIF contains an N-terminal
CBP80-binding domain and a C-terminal MIF4G domain
(37), which shares 33% sequence identity with SLIP1.
Structure-based sequence analysis shows that the SLBP-
binding residues we identified in SLIP1 are conserved in
the MIF4G domain of CTIF (Figure 2B). CTIF may
bind SLBP in a similar manner as observed for SLIP1.
SLIP1-binding motifs are present in additional proteins
To determine what additional proteins might interact with
human SLIP1, we carried out a yeast two-hybrid screen
using a mating library approach that allowed us to screen
10 million clones. We obtained 220 positive clones.
Among these, we identified multiple independent
clones encoding the proteins DBP5, eIF3g and c-myc
(Figure 3A). In addition, we obtained 30hExo (a 30 to 50
exonuclease that forms a specific complex with SLBP and
the stem-loop RNA (38), as well as SLIP1 itself, consistent
with the report that SLIP1 is a dimer (39). To validate the
yeast two-hybrid results, we analyzed the interactions by
in vitro co-precipitation assays with a similar strategy used
previously (23). We synthesized the candidate SLIP1-
binding proteins using an in vitro rabbit reticulocyte
lysate system, labeled them with 35S-methionine and
carried out pull-down assays with purified GST–SLIP1.
All the proteins identified in the two-hybrid assay co-
precipitated with GST–SLIP1 on glutathione beads, with
a similar efficiency as compared with SLBP (Figure 3B).
Sequence analysis of eIF3g and DBP5 revealed the
presence of a stretch of amino-acid residues that is re-
markably similar to the SLIP1-binding motif (SBM) of
SLBP (Figure 3C), while no such sequence motif could
be identified in c-myc or 30-hExo. The binding of c-myc
to SLIP1 is not affected by the mutants in the SBM in
Figure 2D, consistent with the idea that c-myc binds to
another region of SLIP1 (R.L., A.R, W.F.M., not shown).
In both eIF3g and DBP5, the putative SBM sequences are
located in intrinsically unstructured regions at the
N-terminus of the proteins, separate from the folded
domains that are either known or expected from structural
prediction programs (Figure 3D). In both proteins, these
sequences are conserved in vertebrates (Figure 3C) and are
not present in yeast, consistent with the notion that the
yeast genome does not contain a SLIP1 orthologue and
that yeast histone mRNAs feature a canonical poly(A) tail
rather than a specialized stem-loop structure at their 30
end. EIF3g is an outer subunit of the translation initiation
complex that is recruited to the 50 end of the mRNA (40).
Recently, eIF3g has also been shown to interact dir-
ectly with the SLIP1-paralogue CTIF (36). DBP5 is a
Figure 1. Structure of SLIP1 bound to the SBM of SLBP. (A) Structure of the D.r. SLIP1–SLBP complex. SLBP is in blue. SLIP1 is shown with the
4 HEAT repeats in orange and the N- and C-terminal helices in red. The N- and C-termini of SLBP are labeled and the helices of SLIP1 are
numbered. (B) The structure of D.r. SLIP1–SLBP is shown in an orientation related by a 90 rotation around a horizontal axis with respect to panel
A. It is superposed on the MIF4G domain of eIF4G (in gray, PDB code 2VSO). The HEAT repeats of SLIP1 are numbered.
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Figure 2. Determinants and conservation of the SLIP1–SLBP interaction. (A) Close-up view of the interactions between SLIP1 (in orange) and the
SBM of SLBP (in blue). The molecules are in a similar orientation as in Figure 1A. Selected residues are shown in stick representation and labeled.
(B) Alignment of SLIP1 orthologues from Homo sapiens (H.s., Uniprot accession code A9UHW6), Xenopus laevis (X.l., Uniprot accession code
Q801N6) and Danio rerio (D.r., Uniprot accession code Q5EAQ1). The secondary-structure elements observed in the D.r. SLIP1–SLBP89–105 crystal
structure are shown below the sequences (h=helix). The HEAT repeats are labeled according to a superposition with MIF4G structure (PDB code
2VSO). Also labeled are the antiparallel helices of the MIF4G-like fold of SLIP1 (a1–a10). Highlighted in orange are conserved residues. The
residues of SLIP1 interacting with the corresponding motif of SLBP are highlighted above the sequences (with M, in blue). The residues involved in
dimerization are also highlighted (with D, in orange). The alignment also includes the C-terminal portion of the related human protein CTIF
(Uniprot accession code O43310). (C) Alignment of the SBM of SLBP orthologues (H.s., Uniprot accession code Q14493; X.l., Uniprot accession
code P79943; D.r., Uniprot accession code Q7SXI8) is shown with a similar representation as in panel B. The residues of SLBP involved in the
interaction with SLIP1 are highlighted above the sequences (with S, in orange). (D) SLIP1 (lanes 1–4) or SLBP (lanes 5–8) was labeled with 35S-
methionine by in vitro translation in rabbit reticulocyte lysate. The lysates were incubated with GST, GST–SLIP1 or GST–SLIP1m (a mutant with
the R77A/N81A/Q84A substitutions at the SBM-binding site). The complexes were bound to glutathione sepharose and analyzed by SDS gel
electrophoresis and the bound proteins detected by autoradiography.
7964 Nucleic Acids Research, 2013, Vol. 41, No. 16
DEAD-box protein essential for mRNA export [reviewed
in (41)], but not known to connect functionally to either
SLIP1 or SLBP.
SLIP1 interacts with DBP5 in vivo and in vitro
To assess whether SLIP1 interacts with DBP5 in vivo, we
created a stable cell line expressing HA-tagged DBP5 and
carried out immunoprecipitation experiments with an
anti-HA, anti-SLIP1 or a control antibody (anti-myc).
There is not an anti-DBP5 antibody that efficiently
immunoprecipitated endogenous DBP5. The immunopre-
cipitates were resolved by gel electrophoresis and the
proteins were detected by western blotting. We tested
the interaction of HA-tagged-DBP5 with endogenous
SLIP1 after immunoprecipitation with anti-SLIP1
(Figure 4A, top panel): we detected SLIP1 when
immunoprecipitating with the anti-HA antibody (lane 2)
but not with the control anti-myc antibody (lane 4). We
then tested the interaction of endogenous SLIP1 with
HA-DBP5 after immunoprecipitation with anti-SLIP1
(Figure 4A, bottom panel): we detected HA-tagged
DBP5 when immunoprecipitating with the anti-SLIP1
antibody (lane 3) but not with the control antibody
(lane 4). The anti-HA efficiently depleted the HA-DBP5
from the extract (Figure 4A, bottom, lanes 2 and 5).
To assess whether the endogenous SLIP1 and DBP5
interacted, we immunoprecipitated using the anti-SLIP1
antibody, and analyzed the immunoprecipitates for
DBP5 by western blotting with an anti-DBP5 antibody.
The supernatants were also analyzed. The anti-SLIP1
antibody efficiently precipitated the endogenous SLIP1
(Figure 4B, bottom, lanes 3 and 6). A small amount of
DBP5 was co-immunoprecipitated with SLIP1 (Figure 4B,
lane 3) and not with the control antibody (Figure 4B, lane
2), indicating that the endogenous proteins also interacted.
DBP5 binds RNA and ATP using its two RecA
domains, which are also the site for the interaction with
the nucleoporins NUP214 and GLE1 (31,42,43). No
protein has yet been reported to interact with the
N-terminal domain of DBP5, which contains the
putative SBM (at residues 1–20). In GST-pull-down
assays with purified proteins, DBP5 f.l. and DBP51–51
precipitated SLIP1 (Figure 4C, lane 2 and lane 4). We
analyzed the binding quantitatively using ITC. DBP51–51
bound SLIP1 with a Kd of 1.1 mM (Figure 4D). Full-
length DBP5 bound SLIP1 with a Kd of 0.1 mM
(Supplementary Figure S1A), suggesting that the RecA
core also contributes to binding. However, the RecA
core in isolation (DBP5N) showed no detectable
binding to SLIP1 by ITC (Supplementary Figure S1B),
indicating that the major SLIP1-binding site resides in
the N-terminal region of DBP5. We tested whether
SLIP1 and RNA compete for binding to DBP5. We
incubated a single-stranded RNA biotinylated at the 50
end with recombinant proteins and incubated the
samples with AMPPNP before precipitation with
streptavidin magnetic beads. As expected, both DBP5
f.l. and the DEAD-box core (DBP5N) precipitated in
the presence of AMPPNP (Figure 4E, lanes 2 and 4), while
Figure 3. SBMs are present in eIF3g and DBP5. (A) A two-hybrid screen was carried out using SLIP1 as bait. Over 200 positive clones were
characterized by isolating the insert by polymerase chain reaction and digesting the fragment with AluI to identify clones that contained overlapping
inserts. Over 120 of these clones encoded DBP5, eIF3g or myc. A number of clones of different sizes from each were sequenced (indicated in
parentheses). The length of the protein in amino acids is shown, together with the smallest positive clone isolated. Smaller numbers of clones for
several other proteins were obtained. (B) To validate the two-hybrid results, each of the proteins was labeled with 35S-methionine by in vitro
translation and analyzed in a pull-down assay as in Figure 2D. (C) Alignment of the SBM of H.s. SLBP with the putative SBMs we identified
in eIF3g and DBP5 in several vertebrates. (D) Schematic representation of the domain organization of human DBP5 and eIF3g. The folded domains
of DBP5 and eIF3g are boxed and labeled. In each protein, the putative SBMs reside in regions of low complexity that are predicted to be
unstructured.
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Figure 4. DBP5 binds SLIP1 in vivo and in vitro. (A) Top panel: lysates from HeLa cells stably expressing N-terminally HA-tagged DBP5 were
treated with anti-HA (lane 2), anti-SLIP1 (lane 3) or anti-Myc (lane 4) and the immunoprecipitates resolved by SDS gel electrophoresis and probed
by western blotting for SLIP1. Lane 1 is 5% of the input. Note that the anti-SLIP1 efficiently immunoprecipitated endogenous SLIP1. Bottom panel:
lysates from the cells expressing HA-DBP5 were treated with anti-HA (lanes 2, 5), anti-SLIP1 (lanes 3, 6) or anti-GRP94 (as control, lanes 4, 7). The
immunoprecipitates were analyzed for HA–DBP5 by western blotting (lanes 1–4). Five percent of the input is in lane 1. Lanes 5–7 are 5% of the
supernatants after the immunoprecipitation. (B) Lysates were prepared from exponentially growing HeLa cells and treated with either antisera
against the myc epitope (lanes 2, 5) or anti-SLIP1 antisera (lanes 3, 6). The immunoprecipitates were resolved by gel electrophoresis and probed by
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(continued)
a single RecA domain did not (DBP5NC, lane 5) (31).
In the RNA-pull-down assay, SLIP1 co-precipitated with
DBP5 f.l. (Figure 4E, lane 7) but not with DBP5N (lane
9). These results indicate that DBP5 binds SLIP1 mainly
via the N-terminal region and can concomitantly bind
RNA via the RecA domains.
Structure of SLIP1 bound to the N-terminus of DBP5
To obtain the crystal structure of a SLIP1–DBP5
complex, we purified the corresponding zebrafish
orthologues. In pull-down assays, D.r. SLIP1 interacted
with D.r. DBP51–32 (corresponding to human DBP51–32)
(Figure 4C, lane 5). In ITC experiments, D.r. SLIP1
bound D.r. DBP51–32 with a Kd of 2 mM
(Supplementary Figure S1C), comparable with the
binding affinities measured for the human proteins
(Figure 4D). The complex between zebrafish SLIP1 and
DBP51–32 yielded crystals that contain two complexes in
the asymmetric unit. We determined the structure by mo-
lecular replacement using the SLIP1 coordinates and
refined it to 3.25 Å resolution. The final atomic model of
the SLIP1–DBP5 complex has an Rfree of 27.2%, Rwork of
24.5% and good stereochemistry (Table 1). The complex
contains residues 7–222 of SLIP1 and residues 2–20 of
DBP5. No ordered electron density was observed for
residues 21–32 of DBP5, suggesting that this region is
flexible in the crystals we obtained.
The DBP5 SBM forms an a-helix engaged in similar
interactions with SLIP1 as described above for the SBM
of SLBP (Figure 5A). Briefly, Trp6, Val10, Asp11 and
Glu14 of zebrafish DBP5 are at the equivalent structural
positions of Trp94, Val98, Glu99 and Glu102 of zebrafish
SLBP. The small side chain of D.r. DBP5 Ala7 is
accommodated in the shallow pocket of SLIP1 without
significant rearrangements as compared with D.r. SLBP
Gly95. Minor changes occur in the peripheral interactions.
For example, DBP5 Ser5 does not contact SLIP1 Asn81 as
was the case for SLBP Asn93, but a compensatory inter-
action is formed between DBP5 Asp4 and SLIP1 Lys88.
Based on the structural analysis, we tested the effect of
mutations in the interaction of the human f.l. proteins.
In in vitro pull-down experiments, the interaction with
SLIP1 was abolished with a Trp6Ala DBP5 mutant
(Figure 5B, lane 1), homologous to a critical residue for
binding in SLBP and SLIP1, and was drastically reduced
with an Asp11Arg, Glu14Arg DBP5 mutant (Figure 5B,
lane 3, compare with the wild type in lane 4). We conclude
that DBP5 is a bona fide direct binding partner of SLIP1.
The SLIP1 homodimer binds two SBMs simultaneously
SLIP1 is a dimer in solution by ultracentrifugation experi-
ments (39) and by static light scattering (Supplementary
Figure S2A). The SLIP1–DBP5 crystals contain a SLIP1
dimer in the asymmetric unit. The two SLIP1 monomers
are related by a non-crystallographic 2-fold axis (located
between the a9 helices) and interact with the three C-
terminal helices (a8–a10, Figure 6A and B). The dimeriza-
tion interface buries 8.5% of the surface of each monomer
(984 Å2 of surface area buried out of 11 635 Å2), as
calculated using the PISA server (44). The same tail-to-
tail dimer is also observed in the structure of apo SLIP1
(2I2O), independently of the fact that the crystals belong
to a different space group and have different lattice
contacts (Supplementary Figure S2B). This dimer is also
generated by a crystallographic 2-fold axis in the case of
the SLIP1–SLBP crystals (Supplementary Figure S2). The
SLIP1–SLIP1 dimerization interface is formed by evolu-
tionary conserved residues (Figures 2B and 6B). The inter-
molecular interactions are mainly hydrophobic, and
involve Phe181, Leu182, Leu193, Leu196 and Tyr215 of
each monomer (Figure 6B). In addition, there is a
conserved salt bridge between Glu200 of one monomer
and Arg178 of the other monomer.
The SLIP1 homodimer has two SBM-binding sites
(Figure 6A). The SBM helices are more than 25 Å away
from the dimerization interface. Indeed, mutation of
Glu200 in the human orthologue has been shown to
impair SLIP1 dimerization and to maintain SLBP
binding (39). The two parallel SBM helices are positioned
with their C-termini at a 65 Å distance from each other.
SLIP1 can thus in principle bind to two SBM-containing
proteins simultaneously, provided the architecture
and properties of the flanking domains C-terminal to
the SBM do not give rise to steric or electrostatic
clashes. Interestingly, the dimerization interface of
SLIP1 is conserved in CTIF (Figure 2B), suggesting
the possible formation of CTIF–CTIF homodimers
and/or SLIP1–CTIF heterodimers. Indeed, a recent
study has shown that SLIP1, CTIF, SLBP and CBP80
co-immunoprecipitate in an RNA-independent manner,
supporting the existence of SLIP1–CTIF heterodimers
in vivo (36).
CONCLUSIONS
SLIP1 is a MIF4G-like protein that contains the binding
site for a short linear sequence motif (SLiM) that we
named SBM. The SBM is present in SLBP, the protein
Figure 4. Continued
western blotting with anti-DBP5 (top) or anti-SLIP1 (bottom). Five percent of the supernatant remaining after immunoprecipitation was analyzed by
western blotting (lanes 6, 7). Lanes 1 and 5 are 5% of the input. (C) Qualitative in vitro pull-down assays of SLIP1 and DBP5. Human GST–DBP5
f.l. and a fragment containing GST–DBP5 residues 1–51 efficiently precipitated SLIP1 (lanes 2, 4), while no SLIP1 precipitation was observed when
using the N-terminal RecA domain of DBP5 (GST DBP5NC, lane 3). In this assay, D.r. GST–DBP5 residues 1–32 precipitated D.r. SLIP1
(lane 5). Note that GST–D.r. DBP51–32 migrates slower on SDS PAGE than H.s. GST-DBP51–51. Bands and samples were confirmed by mass
spectrometry. (D) Quantitative measurements of the H.s. SLIP1 and DBP51–51 interaction by ITC. Both the raw data and the integrated heat data
are shown. (E) Protein precipitations with biotinylated single-stranded RNA. Purified proteins were mixed with 50 end-biotinylated 20-mer single-
stranded RNA and incubated with or without AMPPNP or ADP, as indicated. Proteins mixtures before (input, 17% of the total) and after
coprecipitation (precipitate) were separated on a 15% (w/v) acrylamide SDS PAGE and visualized using Coomassie stain. The molecular weight
standards are shown.
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that binds the specialized stem-loop structure at the 30 end
of replication-dependent histone mRNAs in metazoans.
The vertebrate orthologues of eIF3g and DBP5 also
contain a SBM sequence, which thus appears to have
evolved convergently in different proteins. In these three
proteins, the SBM has other typical SLiM features (45).
First, it encompasses a sequence region of strong evolu-
tionary conservation amid variable neighboring regions.
Second, it is present in an intrinsically unfolded domain
and becomes folded on binding. Third, it binds SLIP1
with few direct contacts and with low micromolar
affinity. Such a relatively low affinity is typical of transient
and dynamic complexes, and can often be modulated by
posttranslational modifications (45). The regions flanking
the SBMs of both SLBP and eIF3g contain phosphoryl-
ation sites (19,46), which might influence the interaction in
the context of specific cellular conditions.
SLIP1 is a non-canonical MIF4G-like protein, not only
in terms of the fold (i.e. the number of its HEAT repeats)
but also in terms of the oligomeric state. The existence of
SLIP1 as a homodimer raises the possibility that its two
SBM-binding sites can be occupied either by the same or
by different SBM-containing proteins. In the latter case, it
would allow SLIP1 to act as a platform for bridging DBP5
or eIF3g to SLBP. The relevance of these simultaneous
interactions and the emerging models (Figure 6C) are dis-
cussed below. We note that it is also possible that SLIP1
might bridge DBP5 and eIF3g, with an interaction that
would be independent of histone mRNA metabolism.
Indeed, SLIP1 is expected to have additional functions
because knockdown of SLIP1 affects cellular viability
while knockdown of the histone-specific factor SLBP
only affects cell-cycle progression (16,23,47). SLIP1
could also bridge analogous interactions in the context
of a SLIP1–CTIF heterodimer, which would in addition
be able to connect to the cap-binding protein CBP80 (37).
DBP5 (also known as DDX19 in metazoans) belongs to
the DEAD-box family of RNA-dependent ATPases.
DBP5 is essential for the export of poly(A)-containing
mRNPs: it is believed to remodel the mRNP at the cyto-
plasmic side of the nuclear pore complex, removing the
transport factor before the mRNA is released to the cyto-
plasm [reviewed in (41)]. Two cytoplasmic nucleoporins,
GLE1 and NUP214, bind DBP5 directly and activate the
ATPase cycle that likely underlies mRNP remodeling. No
other factor is known to direct DBP5 to its specific RNA
targets. A DBP5–SLIP1/SLIP1–SLBP complex could spe-
cifically target the ATPase to histone-containing mRNPs
(Figure 6C, left panel). Importantly, the loading of DBP5
onto the histone mRNP would not physically interfere
with the domains of DBP5 responsible for RNA binding
and GLE1/NUP214 regulation. This interaction would
rationalize the active role of SLBP in nuclear export in
mammalian cells (14).
It is possible that after export, the SLIP1–SLBP complex
dissociates from DBP5 and then interacts with eIF3g to
stimulate translation of histone mRNA. EIF3g is a periph-
eral component of the mammalian eIF3 complex and is
involved in translational regulation (48). In poly(A)-con-
taining mRNPs, eIF3g interacts directly with PAIP1 and
Figure 5. Structure of SLIP1 bound to the SBM of DBP5. (A) Close-up view of the interactions between SLIP1 (in yellow) and the SBM of DBP5
(in violet). The molecules are in a similar orientation as in Figure 2A. Selected residues are shown in stick representation and labeled. (B) Protein
co-precipitations by GST pull-down assays. GST-tagged human DBP5 wild type or mutants were incubated with SLIP1 in a buffer containing
100mM NaCl. One-sixth of the sample was kept as input control (upper panel), and the rest was co-precipitated with glutathione sepharose beads
(lower panel). Both input and pull-down samples were analyzed on Coomassie stained 15% SDS PAGE. The lane on the left shows a molecular
weight marker.
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stimulates translation (49). PAIP1 is a MIF4G-containing
protein with a multidomain architecture, allowing it to bind
eIF3g and PABP simultaneously (Figure 6C, right panel).
PABP in turn binds the 30 poly(A) tail and eIF4G, a scaf-
folding protein that connects to the 50 cap structure and to
the eIF3e/INT6 subunit (50,51). Mechanistically, eIF3g–
PAIP1 is believed to stabilize the interactions that bring
together the 30 and 50 ends of the message, circularizing it
and facilitating multiple initiation-termination-reinitiation
cycles (49). The eIF3g-PAIP1-PABP interaction can
be readily compared with eIF3g–SLIP1/SLIP1–SLBP
(Figure 6C, right and central panels). In the case of
histone mRNPs, there is no known direct, RNA-independ-
ent SLBP–eIF4G contact similar to that of PABP–eIF4G.
However, eIF3e/INT6 contributes an alternative inter-
action with SLIP1–SLBP that is necessary for efficient
histone mRNA translation (24) (Figure 6C, central
panel). This model rationalizes the finding that both the
50 cap and the 30 stem-loop are required for histone trans-
lation in vivo in mammalian cells (52). It suggests that
histone mRNPs and poly(A)-containing mRNPs might es-
tablish an equivalent network of multiple and reinforcing
interactions to promote efficient translation initiation.
ACCESSION NUMBERS
Atomic coordinates and structure factors have been de-
posited in the Protein data Bank with accession codes
4JHK for the SLIP1–SLBP complex and 4JHJ for the
SLIP1–DBP5 complex.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online:
Supplementary Figures 1 and 2.
Figure 6. Concurrent binding of two SBMs to a SLIP1 homodimer. (A) Structure of the dimeric SLIP1–SLBP complex observed in the crystal
lattice. The two monomers (A and B) are labeled. The vertical line indicates the 2-fold symmetry of the dimer. (B) Close-up view of the dimerization
interface, shown in the same orientation as in panel A. Selected conserved residues are shown in stick representation and labeled. For clarity, helix 8
is shown with 50% transparency. (C) Left panel: model for the involvement of SLBP in histone mRNA export. The SLIP1 heterodimer is shown in
yellow and orange, as in panel A. The model does not include additional levels of regulation, such as phosphorylation (39). Central panel: model for
the mechanisms of translation stimulation of histone mRNAs as compared with that of poly(A)-containing mRNAs (right panel). Arrows indicate
additional interactions reported in the literature.
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